首页 | 本学科首页   官方微博 | 高级检索  
     


Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid
Authors:K A Carmichael  M D Fallon  M Dalinka  F S Kaplan  L Axel  J G Haddad
Affiliation:Philadelphia, Pennsylvania USA
Abstract:A 53-year-old man with a history of long-term aluminum hydroxide antacid ingestion reported diffuse bone pain and multiple stress fractures over a two-year period. An undecalcified transiliac bone biopsy specimen revealed osteomalacia with osteitis fibrosa; plasma parathyroid hormone and cyclic AMP levels were normal. Following withdrawal of antacids and treatment with calcium and phosphorus, an initially elevated plasma, 1,25-dihydroxyvitamin D level fell to within the normal range, accompanied by decreased bone pain, healed stress fractures, and increased axial bone mineral content as determined by computed tomography of lumbar trabecular bone. Phosphate deprivation and 1,25-dihydroxyvitamin D excess may contribute to the poor mineralization and exaggerated resorption of bone observed in this syndrome. The clinical, biochemical, radiologic, and histologic features of previously reported cases are reviewed. Early recognition of this syndrome is important, since appropriate therapy promotes skeletal remineralization and prevents morbidity.
Keywords:Requests for reprints should be addressed to Dr. John G. Haddad   Endocrine Section   Department of Medicine   University of Pennsylvania School of Medicine   531 Johnson Pavilion/G2   Philadelphia   Pennsylvania 19104.
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号